SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600132-21-000011
Filing Date
2021-04-13
Accepted
2021-04-13 08:31:36
Documents
7
Period of Report
2021-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A blph-20210413xdef14a.htm DEF 14A 582309
2 GRAPHIC blph-20210413xdef14a001.jpg GRAPHIC 6438
3 GRAPHIC blph-20210413xdef14a002.jpg GRAPHIC 4080
4 GRAPHIC blph-20210413xdef14a003.jpg GRAPHIC 5994
5 GRAPHIC blph-20210413xdef14a004.jpg GRAPHIC 2594
6 GRAPHIC blph-20210413xdef14a013.jpg GRAPHIC 158610
7 GRAPHIC blph-20210413xdef14a014.jpg GRAPHIC 132370
  Complete submission text file 0001600132-21-000011.txt   1011367
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 21822065
SIC: 2834 Pharmaceutical Preparations